|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.
While Tilt may be a little harder for some to wrap their heads around, it could pay off for cannabis investors.
The only other option is 'to fearfully wait' for the legal-weed industry to expand.
Covered calls may be the best bet -- or wait for a dip.
Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.
A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.
The latest reports about Coke looking into cannabis confirms a broader industry trend.
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.
New fund will take a more international focus as more countries move toward legalizing cannabis for medical use.
Aurora will use Shopify as its e-commerce engine for medical and recreational cannabis distribution globally.
Several micro-cap and private companies are pulling in millions in capital as they prepare for the start of legal adult marijuana use in Canada.
Brian Athaide, formerly the CFO of the company, has been promoted to CEO.
PE-based backers of Canada-based Tilray come from the realm of smart money.
A total of $1.2 billion in debt via 52 transactions was floated by public and private cannabis companies in the six months ended June 29.
The U.S. and China will eventually negotiate, but until then, here is how to play it.